Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumors Meeting Abstract
| Authors: | Doz, F.; van Tilburg, C. M.; Geoerger, B.; Nysom, K.; Øra, I.; Boni, V.; Chisholm, J.; Chung, H. C.; DuBois, S. G.; Melcón, S. G.; Gerber, N. U.; Goto, H.; Grilley-Olsen, J. E.; Hansford, J. R.; Hong, D. S.; Italiano, A.; Kang, H. J.; Capra, M.; Schulte, J. H.; Stefanowicz, J.; Tahara, M.; Ziegler, D. S.; Gavrilovic, I. T.; Norenberg, R.; Dima, L.; De La Cuesta, E.; Laetsch, T. W.; Drilon, A.; Perreault, S. |
| Abstract Title: | Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumors |
| Meeting Title: | 26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 23 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2021 Nov 18-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-11-01 |
| Start Page: | vi73 |
| End Page: | vi74 |
| Language: | English |
| ACCESSION: | WOS:000757356200285 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noab196.283 |
| Notes: | Meeting Abstract: CTNI-58 -- Source: Wos |
